Packaging container
US-D873131-S · Jan 21, 2020 · US
US11160918B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11160918-B2 |
| Application number | US-202016942271-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2020 |
| Priority date | Jul 29, 2019 |
| Publication date | Nov 2, 2021 |
| Grant date | Nov 2, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
According to one aspect of the disclosure, packaging for a sterile syringe having a nominal size of less than 1 mL may include a flexible tray having a cavity for containing the syringe. The cavity may include an opening, one or more sidewalls, and a base. A lip may surround the opening, may extend radially outward from the cavity, and may define a periphery of the tray. A removable cover may have a periphery that is adhered to the lip, and the removable cover may be permeable to a gaseous sterilant, including one or more of vaporized hydrogen peroxide or ethylene oxide. A projection may be associated with the base of the cavity and may extend away from the base of the cavity in a direction opposite to the opening of the cavity.
Opening claim text (preview).
What is claimed is: 1. A packaging comprising: a tray having an opening, a cavity including three cavity portions, a plurality of sidewalls, and a base; a sterile syringe contained within the cavity, wherein the sterile syringe is pre-filled with a medicament; wherein a first cavity portion comprises a plunger of the sterile syringe, a second cavity portion comprises a barrel of the sterile syringe, and a third cavity portion comprises a needle attachment portion of the sterile syringe, wherein the three cavity portions are connected to one another by intermediate narrowed portions, the narrowed portions including a plurality of geometric features projecting into the narrowed portions to position the sterile syringe away from the plurality of sidewalls, and wherein the sterile syringe extends through the narrowed portions, a removable cover sealing the opening, wherein the removable cover is permeable to a gaseous sterilant configured to maintain a sterile barrier, and a projection associated with the tray at a location in line with a portion of the sterile syringe; wherein, in a first state, the projection extends away from the sterile syringe in a direction opposite from the opening of the cavity; wherein the projection is configured to transition from the first state to a second state when subjected to pressure; and wherein, in the second state, the projection is inverted so that a portion of the projection extends towards the portion of the sterile syringe in line with the projection. 2. The packaging of claim 1 , wherein the projection is located in line with a barrel of the sterile syringe when in the first state. 3. The packaging of claim 1 , wherein the medicament is one of aflibercept, ranibizumab, bevacizumab, conbercept, OPT-302, RTH258 (brolocizumab), a pegylated designed ankyrin repeating protein (DARPin), or RG7716. 4. The packaging of claim 1 , wherein the projection is dome-shaped, and wherein a diameter of the base of the dome-shaped projection is approximately 10 mm to 20 mm. 5. The packaging of claim 1 , wherein the three cavity portions are arranged in series along a longitudinal axis of the tray. 6. The packaging of claim 5 , wherein the second cavity portion is located between the first cavity portion and the third cavity portion. 7. The packaging of claim 1 , wherein the tray is formed from a suitable thermoplastic material, including one or more of polypropylene, polystyrene, polyethylene, polycarbonate, polyvinyl chloride, or polyethylene terephthalate glycol. 8. The packaging of claim 1 , wherein a depth of the projection from an apex of the projection to a base of the projection is approximately 5 mm to 6 mm, and a distance between the base of the projection and a portion of the syringe overlying the projection is approximately 3 mm to 4 mm.
one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages {, the recess or recesses being preformed (B65D73/0057, B65D73/0092 take precedence)} · CPC title
for materials not otherwise provided for · CPC title
Containers or packages with special means for dispensing contents (dispensing means incorporated in closures B65D47/00) · CPC title
Peelable seals · CPC title
by expelling contents, e.g. by squeezing the container · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.